Beam Therapeutics Inc.BEAMNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -17.01% | -90.49% | +0.81% | -28.08% | -32.03% |
| Gross Profit Growth | +0.00% | -140.53% | +0.00% | -892.49% | +0.00% |
| EBITDA Growth | +0.00% | -168.44% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | -175.30% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | -163.27% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | -161.58% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | -163.01% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.28% | +2.43% | +7.68% | +23.91% | +24.46% |
| Weighted Average Shares Diluted Growth | +4.28% | +0.15% | +7.68% | +23.91% | +24.46% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -156.54% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -160.34% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -9.23% | -24.38% | +7.88% | +10.30% | +11.93% |
| Book Value per Share Growth | -2.58% | -27.02% | +14.18% | -1.09% | -1.92% |
| Debt Growth | -6.10% | -6.52% | -5.94% | -6.31% | -6.57% |
| R&D Expense Growth | -5.79% | -27.58% | +16.50% | +16.91% | +16.46% |
| SG&A Expenses Growth | +4.35% | -33.74% | +4.55% | -9.34% | +0.85% |